TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
EXOZ

eXoZymes, Inc.

Healthcare · Biotechnology

6.40$ +3.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow EXOZ
Line item 2021 2022 2023 2024 2025
– – – – –
– +148.7% +33.3% +35.8% -119.8%
– +9.1% +30.0% +299.8% +76.6%
– – – -1,923.7% –
– -56.0% +55.2% +37.3% -57.1%
– -72.1% +256.8% +15.4% -58.2%
– – – – –
– -41.4% -26.2% +1,751.8% -100.1%
– -97.4% -4,671.1% – -169.2%
– – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?